MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.trim.2022.101738

Медицинская библиотека · Transplant immunology · 2022

A novel xenograft model of human hepatocellular carcinoma in immunocompetent mice based on the microcarrier-6.

Bi Yanzhen, Li Shanshan, Tang Huixin, Wang Quanquan, Wang Quanyi, Yang Yonghong, Zhang Xiaobei, Shu Zhenfeng, Duan Zhongping, Chen Yu, Hong Feng

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors that threaten human health; thus, the establishment of an animal model with clinical features similar to human hepatocellular carcinoma is of important practical significance.

METHODS

Taking advantage of the novel microcarrier-6, human HCC cells were injected into immunocompetent mice to establish a novel human HCC patient-derived xenograft (PDX) model. Primary HCC cells were isolated from fresh hepatocellular carcinoma tissues, which were subsequently co-cultured with microcarrier-6 to construct a three-dimensional tumor cell culture model in vitro. The HCC-microcarrier complex was implanted into mice by subcutaneous inoculation, and the tumor formation time, tumor formation rate, and pathological manifestation were recorded. Changes of immune parameters in mice were detected by flow cytometry.

RESULTS

The success rate was 60% (6/10) in the establishment of hepatocellular carcinoma PDX mouse model, and the total tumor formation rate of the tumor-forming model is 90-100%. H&E staining and immunohistochemical experiments indicate that the model well retained the characteristics of the primary tumor. Interestingly, M2 macrophages in tumor-bearing mice increased significantly, and the levels of CD4+ T cells were significantly reduced.

CONCLUSIONS

Through the application of the microcarrier-6 in immunocompetent mice, we successfully established a novel human HCC PDX model, which can be used to better study and further elucidate the occurrence and pathogenic mechanism of HCC, improve the predictability of toxicity and drug sensitivity in HCC.

Для цитирования: Bi Yanzhen, Li Shanshan, Tang Huixin, Wang Quanquan, Wang Quanyi, Yang Yonghong, Zhang Xiaobei, Shu Zhenfeng, Duan Zhongping, Chen Yu, Hong Feng. A novel xenograft model of human hepatocellular carcinoma in immunocompetent mice based on the microcarrier-6.. Transplant immunology. 2022. DOI: 10.1016/j.trim.2022.101738.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.